<H1>Chapter DOI: 10.1208/aapsj070119<br/>Cited-By Count: 6</H1><table border="1" width="30%"><tr><td>Total References</td><td>107</td></tr><tr><td>Springer references</td><td>6</td></tr><tr><td>Non Springer references</td><td>101</td></tr><tr><td>BibStructured Count</td><td width="10%">106</td></tr><tr><td>BibUnstructured Count</td><td width="10%">1</td></tr><tr><td>DOI already available in SpringerLink</td><td>2</td></tr><tr><td>Additional DOI extracted from CrossRef-Meta</td><td>58</td></tr><tr><td>Additional DOI extracted from CrossRef-Web</td><td>0</td></tr><tr><td>Additional DOI extracted from ResearchGate-Web</td><td>0</td></tr><tr><td>Additional DOI extracted from SpringerLink-FUZZY-Search</td><td>0</td></tr><tr><td>Spelling Mistakes</td><td>NULL</td></tr><tr><td>Wrong DOI</td><td>0</td></tr><tr><td>ISBN</td><td>NULL</td></tr><tr><td>Web Link</td><td>NULL</td></tr><tr><td>DOI Obtained For Springer Published</td><td>5</td></tr><tr><td>DOI Obtained For Non Springer</td><td>53</td></tr><tr><td>DOI Obtained From Structured Ref</td><td>58</td></tr><tr><td>DOI Obtained From Unstructured Ref</td><td>0</td></tr><tr><td>Valid DOI Enriched</td><td>47</td></tr></table></br></br><table border="1">
<tr><th>Bib. ID</th><th>Ref. Type</th><th>References</th><th>DOI</th><th>Suspected DOI</th><th>DOI Source</th><th>Validated Elements</th><th>Validation Source</th></tr><tr><td>CR1</td><td>BibArticle</td><td>Clarke PB. Nicotine and smoking: a perspective from animal studies.<Emphasis Type="Italic">Psychopharmacology (Berl).</Emphasis> 1987;92:135&#8211;143.</td><td><a href=http://dx.doi.org/10.1007/BF00177905>10.1007/BF00177905</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>Year, Author_FamilyName_1, ArticleTitle, JournalTitle, VolumeID</td><td>CrossRef</td></tr><tr><td>CR2</td><td>BibArticle</td><td>Pomerleau CS, Pomerleau OF. Euphoriant effects of nicotine in smokers. Euphoriant effects of nicotine in smokers.<Emphasis Type="Italic">Psychopharmacology (Berl).</Emphasis> 1992;108:460&#8211;465.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR3</td><td>BibArticle</td><td>Balfour DJ. The neurobiology of tobacco dependence: a commentary.<Emphasis Type="Italic">Respiration</Emphasis>. 2002;69:7&#8211;11.</td><td><a href=http://dx.doi.org/10.1159/000049362>10.1159/000049362</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>ArticleTitle, FirstPage, JournalTitle, VolumeID, Year, Author_FamilyName_1</td><td>CrossRef</td></tr><tr><td>CR4</td><td>BibArticle</td><td>Koob GF. Neural mechanisms of drug reinforcement.<Emphasis Type="Italic">Ann N Y Acad Sci.</Emphasis> 1992;654:171&#8211;191.</td><td><a href=http://dx.doi.org/10.1111/j.1749-6632.1992.tb25966.x>10.1111/j.1749-6632.1992.tb25966.x</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>VolumeID, ArticleTitle, FirstPage, Author_FamilyName_1, Year</td><td>CrossRef</td></tr><tr><td>CR5</td><td>BibArticle</td><td>Corrigall WA, Franklin KBJ, Coen KM, Clarke PBS. The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine.<Emphasis Type="Italic">Psychopharmacology (Berl).</Emphasis> 1992;107:285&#8211;289.</td><td><a href=http://dx.doi.org/10.1007/BF02245149>10.1007/BF02245149</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>ArticleTitle, FirstPage, Author_FamilyName_2, JournalTitle, VolumeID, Year, Author_FamilyName_1</td><td>CrossRef</td></tr><tr><td>CR6</td><td>BibArticle</td><td>Stolerman IP, Jarvis MJ. The scientific case that nicotine is addictive.<Emphasis Type="Italic">Psychopharmacology (Berl).</Emphasis> 1995;117:2&#8211;10.</td><td><a href=http://dx.doi.org/10.1007/BF02245088>10.1007/BF02245088</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>Author_FamilyName_1, Year, JournalTitle, Author_FamilyName_2, VolumeID, ArticleTitle, FirstPage</td><td>CrossRef</td></tr><tr><td>CR7</td><td>BibArticle</td><td>Pontieri F, Tanda G, Orgi F, DiChiara G. Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs.<Emphasis Type="Italic">Nature</Emphasis>. 1996;382:255&#8211;257.</td><td><a href=http://dx.doi.org/10.1038/382255a0>10.1038/382255a0</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>JournalTitle, Author_FamilyName_2, VolumeID, ArticleTitle, FirstPage, Author_FamilyName_1, Year</td><td>CrossRef</td></tr><tr><td>CR8</td><td>BibArticle</td><td>Spanagel R, Weiss F. The dopamine hypothesis of reward: past and current status.<Emphasis Type="Italic">Trands Neurosci.</Emphasis> 1999;22:521&#8211;527.</td><td><a href=http://dx.doi.org/10.1016/S0166-2236(99)01447-2>10.1016/S0166-2236(99)01447-2</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>Year, Author_FamilyName_1, FirstPage, ArticleTitle, VolumeID, Author_FamilyName_2</td><td>CrossRef</td></tr><tr><td>CR9</td><td>BibArticle</td><td>Di Chiara G. Role of dopamine in the behavioural actions of nicotine related to addiction.<Emphasis Type="Italic">Eur J Pharmacol.</Emphasis> 2000;393:295&#8211;314.</td><td><a href=http://dx.doi.org/10.1016/S0014-2999(00)00122-9>10.1016/S0014-2999(00)00122-9</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>FirstPage, ArticleTitle, VolumeID, Year, Author_FamilyName_1</td><td>CrossRef</td></tr><tr><td>CR10</td><td>BibArticle</td><td>Wise RA. Addiction becomes a brain disease.<Emphasis Type="Italic">Neuron</Emphasis>. 2000;26:27&#8211;33.</td><td><a href=http://dx.doi.org/10.1016/S0896-6273(00)81134-4>10.1016/S0896-6273(00)81134-4</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>FirstPage, ArticleTitle, VolumeID, JournalTitle, Year, Author_FamilyName_1</td><td>CrossRef</td></tr><tr><td>CR11</td><td>BibArticle</td><td>Wise RA, Bozarth MA. A psychomotor stimulant theory of addiction.<Emphasis Type="Italic">Psychol Rev.</Emphasis> 1987;94:469&#8211;492.</td><td><a href=http://dx.doi.org/10.1037/0033-295X.94.4.469>10.1037/0033-295X.94.4.469</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>Author_FamilyName_1, Year, VolumeID, Author_FamilyName_2, FirstPage, ArticleTitle</td><td>CrossRef</td></tr><tr><td>CR12</td><td>BibArticle</td><td>Bardo MT. Neuropharmacological mechanisms of drug reward: beyond dopamine in the nucleus accumbens.<Emphasis Type="Italic">Crit Rev Neurobiol.</Emphasis> 1998;12:37&#8211;67.</td><td><a href=http://dx.doi.org/10.1615/CritRevNeurobiol.v12.i1-2.30>10.1615/CritRevNeurobiol.v12.i1-2.30</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>Author_FamilyName_1, Year, JournalTitle, VolumeID, ArticleTitle, FirstPage</td><td>CrossRef</td></tr><tr><td>CR13</td><td>BibArticle</td><td>Koob GF. The role of the striatopallidal and extended amygdala systems in drug addiction.<Emphasis Type="Italic">Ann N Y Acad Sci.</Emphasis> 1999;877:445&#8211;460.</td><td><a href=http://dx.doi.org/10.1111/j.1749-6632.1999.tb09282.x>10.1111/j.1749-6632.1999.tb09282.x</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>Year, Author_FamilyName_1, ArticleTitle, FirstPage, VolumeID</td><td>CrossRef</td></tr><tr><td>CR14</td><td>BibArticle</td><td>Di Chiara G, Bassareo V, Fenu S, et al. Dopamine and drug addiction: the nucleus accumbens shell connection.<Emphasis Type="Italic">Neuropharmacology</Emphasis>. 2004;47:227&#8211;241.</td><td><a href=http://dx.doi.org/10.1016/j.neuropharm.2004.06.032>10.1016/j.neuropharm.2004.06.032</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>FirstPage, ArticleTitle, VolumeID, JournalTitle, Author_FamilyName_2, Year, Author_FamilyName_1</td><td>CrossRef</td></tr><tr><td>CR15</td><td>BibChapter</td><td>Fibiger HC, Phillips AG. Role of catecholamine transmitters in brain reward systems. In: Engel J, Oreland L, eds.<Emphasis Type="Italic">Brain Reward Systems and Abuse</Emphasis>. New York, NY: Raven Press; 1987:61&#8211;74.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR16</td><td>BibArticle</td><td>Mansvelder HD, McGehee DS. Cellular and synaptic mechanisms of nicotine addiction.<Emphasis Type="Italic">J Neurobiol</Emphasis>. 2002;53:606&#8211;617.</td><td><a href=http://dx.doi.org/10.1002/neu.10148>10.1002/neu.10148</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>FirstPage, ArticleTitle, VolumeID, Author_FamilyName_2, Year, Author_FamilyName_1</td><td>CrossRef</td></tr><tr><td>CR17</td><td>BibArticle</td><td>Mathieu-Kia AM, Kellog SH, Butelman ER, Kreek MJ. Nicotine addiction: insights from recent animal studies.<Emphasis Type="Italic">Psychopharmacology (Berl)</Emphasis>. 2002;162:102&#8211;118.</td><td><a href=http://dx.doi.org/10.1007/s00213-002-1096-0>10.1007/s00213-002-1096-0</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>ArticleTitle, FirstPage, JournalTitle, VolumeID, Year, Author_FamilyName_1</td><td>CrossRef</td></tr><tr><td>CR18</td><td>BibArticle</td><td>Berridge KC, Robinson TE. What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience?.<Emphasis Type="Italic">Brain Res Brain Res Rev.</Emphasis> 1998;28:309&#8211;369.</td><td><a href=http://dx.doi.org/10.1016/S0165-0173(98)00019-8>10.1016/S0165-0173(98)00019-8</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>Author_FamilyName_1, Year, Author_FamilyName_2, VolumeID, ArticleTitle, FirstPage</td><td>CrossRef</td></tr><tr><td>CR19</td><td>BibArticle</td><td>Shima K, Tanji J. Role for cingulate motor area cells in voluntary movement selection based on reward.<Emphasis Type="Italic">Science.</Emphasis> 1998;282:1335&#8211;1338.</td><td><a href=http://dx.doi.org/10.1126/science.282.5392.1335>10.1126/science.282.5392.1335</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>Year, Author_FamilyName_1, ArticleTitle, FirstPage, JournalTitle, VolumeID</td><td>CrossRef</td></tr><tr><td>CR20</td><td>BibArticle</td><td>Rose JE, Behm FM. Extinguishing the rewarding value of smoke cues: pharmacological and behavioral treatments.<Emphasis Type="Italic">Nicotine Tob Res.</Emphasis> 2004;6:523&#8211;532.</td><td><a href=http://dx.doi.org/10.1080/14622200410001696501>10.1080/14622200410001696501</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>Author_FamilyName_1, Year, VolumeID, Author_FamilyName_2, FirstPage, ArticleTitle</td><td>CrossRef</td></tr><tr><td>CR21</td><td>BibArticle</td><td>Brody AL, Mandelkern MA, Lee G, et al. Attenuation of cue-induced cigarette craving and anterior cingulate cortex activation in bupropion-treated smokers: a preliminary study.<Emphasis Type="Italic">Psychiatry Res.</Emphasis> 2004;130:269&#8211;281.</td><td><a href=http://dx.doi.org/10.1016/j.pscychresns.2003.12.006>10.1016/j.pscychresns.2003.12.006</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>Author_FamilyName_1, Year, VolumeID, Author_FamilyName_2, FirstPage, ArticleTitle</td><td>CrossRef</td></tr><tr><td>CR22</td><td>BibArticle</td><td>Martin-Soelch C, Leenders KL, Chevalley AF, et al. Reward mechanisms in the brain and their role in dependence: evidence from neuro-physiological and neuroimaging studies.<Emphasis Type="Italic">Brain Res Brain Res Rev.</Emphasis> 2001;36:139&#8211;149.</td><td>&nbsp;</td><td><a href=http://dx.doi.org/10.1016/S0165-0173(01)00089-3>10.1016/S0165-0173(01)00089-3</a></td><td><b>CrossRef-Meta</b></td>
<td>Author_FamilyName_2, VolumeID, FirstPage, Author_FamilyName_1, Year</td><td>CrossRef</td></tr><tr><td>CR23</td><td>BibArticle</td><td>Stein EA, Pankiewicz J, Harsch HH, et al. Nicotine-induced limbic cortical activation in the human brain: a functional MRI study.<Emphasis Type="Italic">Am J Psychiatry.</Emphasis> 1998;155:1009&#8211;1015.</td><td><a href=http://dx.doi.org/10.1176/ajp.155.8.1009>10.1176/ajp.155.8.1009</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>ArticleTitle, FirstPage, Author_FamilyName_2, VolumeID, Year, Author_FamilyName_1</td><td>CrossRef</td></tr><tr><td>CR24</td><td>BibArticle</td><td>Barrett SP, Boileau I, Okker J, Pihl RO, Dagher A. The hedonic response to cigarette smoking is proportional to dopamine release in the human striatum as measured by positron emission tomography and [<Superscript>11</Superscript>C]raclopride.<Emphasis Type="Italic">Synapse</Emphasis>. 2004;54:65&#8211;71.</td><td><a href=http://dx.doi.org/10.1002/syn.20066>10.1002/syn.20066</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>Year, Author_FamilyName_1, FirstPage, VolumeID, Author_FamilyName_2, JournalTitle</td><td>CrossRef</td></tr><tr><td>CR25</td><td>BibArticle</td><td>Parker MJ, Beck A, Luetje CW. Neuronal nicotinic receptor &#946;2 and &#946;4 subunits confer large differences in agonist binding affinity.<Emphasis Type="Italic">Mol Pharmacol</Emphasis>. 1998;54:1132&#8211;1139.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR26</td><td>BibArticle</td><td>McGehee DS, Role LW. Physiological diversity of nicotinic acetyl-choline receptors expressed by vertebrate neurons.<Emphasis Type="Italic">Annu Rev Physiol.</Emphasis> 1995;57:521&#8211;546.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR27</td><td>BibArticle</td><td>Wonnacott S. Presynaptic nicotinic ACh receptors.<Emphasis Type="Italic">Trends Neurosci</Emphasis>. 1997;20:92&#8211;98.</td><td><a href=http://dx.doi.org/10.1016/S0166-2236(96)10073-4>10.1016/S0166-2236(96)10073-4</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>Year, Author_FamilyName_1, FirstPage, ArticleTitle, VolumeID</td><td>CrossRef</td></tr><tr><td>CR28</td><td>BibArticle</td><td>Luetje CW. Getting past the asterisk: the subunit composition of presynaptic nicotinic receptors that modulate striatal dopamine release.<Emphasis Type="Italic">Mol Pharmacol</Emphasis>. 2004;65:1333&#8211;1335.</td><td><a href=http://dx.doi.org/10.1124/mol.65.6.1333>10.1124/mol.65.6.1333</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>Author_FamilyName_1, Year, VolumeID, FirstPage, ArticleTitle</td><td>CrossRef</td></tr><tr><td>CR29</td><td>BibArticle</td><td>Gotti C, Clementi F. Neuronal nicotinic receptors: from structure to pathology.<Emphasis Type="Italic">Prog Neurobiol</Emphasis>. 2004;74:363&#8211;396.</td><td><a href=http://dx.doi.org/10.1016/j.pneurobio.2004.09.006>10.1016/j.pneurobio.2004.09.006</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>Year, Author_FamilyName_1, FirstPage, ArticleTitle, VolumeID, Author_FamilyName_2</td><td>CrossRef</td></tr><tr><td>CR30</td><td>BibArticle</td><td>Irvine JE, Hendericks PS, Brandon TH. The increasing recalcitrance of smokers in clinical trials II: pharmacotherapy trials.<Emphasis Type="Italic">Nicotine Tob Res.</Emphasis> 2003;5:27&#8211;35.</td><td><a href=http://dx.doi.org/10.1080/1462220031000070534>10.1080/1462220031000070534</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>VolumeID, ArticleTitle, FirstPage, Author_FamilyName_1, Year</td><td>CrossRef</td></tr><tr><td>CR31</td><td>BibArticle</td><td>Hurt RD, Krook JE, Croghan IT, et al. Nicotine patch therapy based on smoking rate followed by bupropion for prevention of relapse to smoking.<Emphasis Type="Italic">J Clin Oncol.</Emphasis> 2003;21:914&#8211;920.</td><td><a href=http://dx.doi.org/10.1200/JCO.2003.08.160>10.1200/JCO.2003.08.160</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>Year, Author_FamilyName_1, FirstPage, ArticleTitle, VolumeID</td><td>CrossRef</td></tr><tr><td>CR32</td><td>BibArticle</td><td>George TP, O'Malley SS. Current pharmacological treatments for nicotine dependence.<Emphasis Type="Italic">Trends Pharmacol Sci.</Emphasis> 2004;25:42&#8211;48.</td><td><a href=http://dx.doi.org/10.1016/j.tips.2003.11.003>10.1016/j.tips.2003.11.003</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>FirstPage, ArticleTitle, VolumeID, Author_FamilyName_2, Year, Author_FamilyName_1</td><td>CrossRef</td></tr><tr><td>CR33</td><td>BibArticle</td><td>Wileyto P, Patterson F, Niaura R, et al. Do small lapses predict relapse to smoking behavior under bupropion treatment?.<Emphasis Type="Italic">Nicotine Tob Res.</Emphasis> 2004;6:357&#8211;366.</td><td><a href=http://dx.doi.org/10.1080/1462220042000202463>10.1080/1462220042000202463</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>ArticleTitle, FirstPage, Author_FamilyName_2, VolumeID, Year, Author_FamilyName_1</td><td>CrossRef</td></tr><tr><td>CR34</td><td>BibArticle</td><td>Richelson E, Pfenning M. Blockade by antidepressants and related compounds of biogenic amine uptake into rat brain synaptosomes: most antidepressants selectively block norepinephrine uptake.<Emphasis Type="Italic">Eur J Pharmacol</Emphasis>. 1984;104:277&#8211;286.</td><td><a href=http://dx.doi.org/10.1016/0014-2999(84)90403-5>10.1016/0014-2999(84)90403-5</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>Author_FamilyName_2, VolumeID, ArticleTitle, FirstPage, Author_FamilyName_1, Year</td><td>CrossRef</td></tr><tr><td>CR35</td><td>BibArticle</td><td>Nomikos GG, Damsma G, Wenkstern D, Fibiger HC. Acute effects of bupropion on extracellular dopamine concentrations in rat striatum and nucleus accumbens studied by in vivo microdialysis.<Emphasis Type="Italic">Neuropsychopharmacology.</Emphasis> 1989;2:273&#8211;279.</td><td><a href=http://dx.doi.org/10.1016/0893-133X(89)90031-6>10.1016/0893-133X(89)90031-6</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>VolumeID, JournalTitle, FirstPage, ArticleTitle, Author_FamilyName_1, Year</td><td>CrossRef</td></tr><tr><td>CR36</td><td>BibArticle</td><td>Ascher JA, Cole JO, Colin JN, et al. Bupropion: a review of its mechanism of antidepressant activity.<Emphasis Type="Italic">J Clin Psychiatry.</Emphasis> 1995;56:395&#8211;401.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR37</td><td>BibArticle</td><td>Li SX, Perry KW, Wong DT. Influence of fluoxetine on the ability of bupropion to modulate extracellular dopamine and norepinephrine concentrations in three mesocorticolimbic areas of rats.<Emphasis Type="Italic">Neuropharmacology</Emphasis>. 2002;42:181&#8211;190.</td><td><a href=http://dx.doi.org/10.1016/S0028-3908(01)00160-5>10.1016/S0028-3908(01)00160-5</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>ArticleTitle, FirstPage, JournalTitle, Author_FamilyName_2, VolumeID, Year, Author_FamilyName_1</td><td>CrossRef</td></tr><tr><td>CR38</td><td>BibArticle</td><td>Damaj MI, Carroll FI, Eaton JB, et al. Enantioselective effects of hydroxy metabolites of bupropion on behavior and on function of monoamine transporters and nicotinic receptors.<Emphasis Type="Italic">Mol Pharmacol</Emphasis>. 2004;66:675&#8211;682.</td><td><a href=http://dx.doi.org/10.1124/mol.104.001313>10.1124/mol.104.001313</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>ArticleTitle, FirstPage, VolumeID, Year, Author_FamilyName_1</td><td>CrossRef</td></tr><tr><td>CR39</td><td>BibArticle</td><td>Fryer JD, Lukas RJ. Noncompetitive functional inhibition at diverse, human nicotinic acetylcholine receptor subtypes by pupropion, phencyclidine, and ibogaine.<Emphasis Type="Italic">J Pharmacol Exp Ther.</Emphasis> 1999;288:88&#8211;92.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR40</td><td>BibArticle</td><td>Slemmer JE, Martin BR, Damaj MI. Bupropion is a nicotinic antagonist.<Emphasis Type="Italic">J Pharmacol Exp Ther.</Emphasis> 2000;295:321&#8211;327.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR41</td><td>BibArticle</td><td>Miller DK, Sumithran SP, Dwoskin LP. Bupropion inhibits nicotine-evoked [(3)H]overflow from rat striatal slices preloaded with [(3)H]dopamine and from rat hippocampal slices preloaded with [(3)H]norepinephrine.<Emphasis Type="Italic">J Pharmacol Exp Ther.</Emphasis> 2002;302:1113&#8211;1122.</td><td>&nbsp;</td><td><a href=http://dx.doi.org/10.1124/jpet.102.033852>10.1124/jpet.102.033852</a></td><td><b>CrossRef-Meta</b></td>
<td>VolumeID, FirstPage, Author_FamilyName_1, Year</td><td>CrossRef</td></tr><tr><td>CR42</td><td>BibArticle</td><td>Gumilar F, Arias HR, Spitzmaul G, Bouzat C. Molecular mechanisms of inhibition of nicotinic acetylcholine receptors by tricyclic antidepressants.<Emphasis Type="Italic">Neuropharmacology</Emphasis>. 2003;45:964&#8211;976.</td><td><a href=http://dx.doi.org/10.1016/S0028-3908(03)00247-8>10.1016/S0028-3908(03)00247-8</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>Author_FamilyName_1, Year, JournalTitle, VolumeID, ArticleTitle, FirstPage</td><td>CrossRef</td></tr><tr><td>CR43</td><td>BibArticle</td><td>Grady SR, Marks MJ, Wonnacott S, Collins AC. Characterization of nicotinic receptor-mediated [<Superscript>3</Superscript>H]dopamine release from synaptosomes prepared from mouse striatum.<Emphasis Type="Italic">J Neurochem.</Emphasis> 1992;59:848&#8211;856.</td><td>&nbsp;</td><td><a href=http://dx.doi.org/10.1111/j.1471-4159.1992.tb08322.x>10.1111/j.1471-4159.1992.tb08322.x</a></td><td><b>CrossRef-Meta</b></td>
<td>Author_FamilyName_1, Year, VolumeID, Author_FamilyName_2, FirstPage</td><td>CrossRef</td></tr><tr><td>CR44</td><td>BibArticle</td><td>Teng L, Crooks PA, Buxton ST, Dwoskin LP. Nicotinic-receptor mediation of S(-)-nornicotine-evoked [<Superscript>3</Superscript>H]-overflow from rat striatal slices preloaded with [<Superscript>3</Superscript>H]-dopamine.<Emphasis Type="Italic">J Pharmacol Exp Ther.</Emphasis> 1997;283:778&#8211;787.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR45</td><td>BibArticle</td><td>Wilkins LH, Haubner A, Ayers JT, Crooks PA, Dwoskin LP.<Emphasis Type="Italic">N-n</Emphasis>-Alkylnicotinium analogs, a novel class of nicotinic receptor antagonist: Inhibition of S(-)-nicotine-evoked [<Superscript>3</Superscript>H]dopamine overflow from superfused rat striatal slices.<Emphasis Type="Italic">J Pharmacol Exp Ther.</Emphasis> 2002;301:1088&#8211;1096.</td><td>&nbsp;</td><td><a href=http://dx.doi.org/10.1124/jpet.301.3.1088>10.1124/jpet.301.3.1088</a></td><td><b>CrossRef-Meta</b></td>
<td>Year, Author_FamilyName_1, FirstPage, VolumeID</td><td>CrossRef</td></tr><tr><td>CR46</td><td>BibArticle</td><td>Rose JE, Behm FM, Westman EC, Levin ED, Stein RM, Ripka GV. Mecamylamine combined with nicotine skin patch facilitates smoking cessation beyond nicotine patch treatment alone.<Emphasis Type="Italic">Clin Pharmacol Ther.</Emphasis> 1994;56:86&#8211;99.</td><td><a href=http://dx.doi.org/10.1038/clpt.1994.105>10.1038/clpt.1994.105</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR47</td><td>BibArticle</td><td>Rose JE, Westman EC, Behm FM, Johnson MP, Goldberg JS. Blockade of smoking satisfaction using the peripheral nicotinic antagonist trimethaphan.<Emphasis Type="Italic">Pharmacol Biochem Behav.</Emphasis> 1999;62:165&#8211;172.</td><td><a href=http://dx.doi.org/10.1016/S0091-3057(98)00153-1>10.1016/S0091-3057(98)00153-1</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>FirstPage, ArticleTitle, VolumeID, Author_FamilyName_2, Year, Author_FamilyName_1</td><td>CrossRef</td></tr><tr><td>CR48</td><td>BibArticle</td><td>Anand R, Conroy WG, Schoepfer R, Whiting P, Lindstrom J. Neuronal nicotinic acetylcholine receptors expressed in<Emphasis Type="Italic">Xenopus</Emphasis> oocytes have a pentameric quaternary structure.<Emphasis Type="Italic">J Biol Chem.</Emphasis> 1991;266:11192&#8211;11198.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR49</td><td>BibArticle</td><td>Cooper E, Couturier S, Ballivet M. Pentameric structure and subunit stoichiometry of a neuronal nicotinic acetylcholine receptor.<Emphasis Type="Italic">Nature</Emphasis>. 1991;350:235&#8211;238.</td><td><a href=http://dx.doi.org/10.1038/350235a0>10.1038/350235a0</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>FirstPage, ArticleTitle, VolumeID, JournalTitle, Author_FamilyName_2, Year, Author_FamilyName_1</td><td>CrossRef</td></tr><tr><td>CR50</td><td>BibArticle</td><td>Boorman JP, Groot-Kormelink PJ, Sivilotti LG. Stoichiometry of human recombinant neuronal nicotinic receptors containing the &#946;3 subunit expressed in Xenopus oocytes.<Emphasis Type="Italic">J Physiol</Emphasis>. 2000;529:565&#8211;577.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR51</td><td>BibArticle</td><td>Perry DC, Xiao Y, Nguyen HN, Musachio JL, Davila-Garcia MI, Kellar KJ. Measuring nicotinic receptors with characteristics of alpha4beta2, alpha3beta2 and alpha3beta4 subtypes in rat tissues by autoradiography.<Emphasis Type="Italic">J Neurochem</Emphasis>. 2002;82:468&#8211;481.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR52</td><td>BibArticle</td><td>Le Novere N, Changeux JP. Molecular evolution of the nicotinic acetylcholine receptor: an example of multigene family in excitable cells.<Emphasis Type="Italic">J Mol Evol.</Emphasis> 1995;40:155&#8211;172.</td><td><a href=http://dx.doi.org/10.1007/BF00167110>10.1007/BF00167110</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>JournalTitle, Author_FamilyName_2, VolumeID, ArticleTitle, FirstPage, Author_FamilyName_1, Year</td><td>CrossRef</td></tr><tr><td>CR53</td><td>BibChapter</td><td>Lindstrom J. Neuronal nicotinic acetylcholine receptors. In: Narahashi T, ed.<Emphasis Type="Italic">Ion Channels</Emphasis>. vol. 4. New York, NY: Plenum Press; 1996:377&#8211;450.</td><td>&nbsp;</td><td><a href=http://dx.doi.org/10.1007/978-1-4899-1775-1>10.1007/978-1-4899-1775-1</a></td><td><b>CrossRef-Meta</b></td>
<td>Year, BookTitle</td><td>CrossRef</td></tr><tr><td>CR54</td><td>BibChapter</td><td>Lindstrom J. The structures of neuronal nicotinic receptors. In: Clementi F, Fornasari D, Gotti C, eds.<Emphasis Type="Italic">Handbook of Experimental Pharmacology: Neuronal Nicotinic Receptors</Emphasis>, vol. 144. Berlin, Germany: Springer; 2000:101&#8211;162.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR55</td><td>BibArticle</td><td>Elgoyhen AB, Vetter DE, Katz E, Rothlin CV, Heinemann SF, Boulter J. &#945;10: a determinant of nicotinic cholinergic receptor function in mammalian vestibular and cochlear mechanosensory hair cells.<Emphasis Type="Italic">Proc Natl Acad Sci USA.</Emphasis> 2001;98:3501&#8211;3506.</td><td>&nbsp;</td><td><a href=http://dx.doi.org/10.1073/pnas.051622798>10.1073/pnas.051622798</a></td><td><b>CrossRef-Meta</b></td>
<td>Year, Author_FamilyName_1, FirstPage, VolumeID, Author_FamilyName_2</td><td>CrossRef</td></tr><tr><td>CR56</td><td>BibArticle</td><td>Luetje CW, Patrick J. Both alpha and beta-subunits contribute to the agonist sensitivity of neuronal nicotinic acetylcholine receptors.<Emphasis Type="Italic">J Neurosci.</Emphasis> 1991;11:837&#8211;845.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR57</td><td>BibArticle</td><td>Harvey SC, Luetje CW. Determinants of competitive antagonist sensitivity on neuronal nicotinic receptor&#946; subunits.<Emphasis Type="Italic">J Neurosci.</Emphasis> 1996;16:3798&#8211;3806.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR58</td><td>BibArticle</td><td>Ramirez-Latorre J, Yu CR, Qu X, Perin F, Karlin A. Functional contributions of &#945;5 subunit to neuronal acetylcholine receptor channels.<Emphasis Type="Italic">Nature</Emphasis>. 1996;380:347&#8211;351.</td><td><a href=http://dx.doi.org/10.1038/380347a0>10.1038/380347a0</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>JournalTitle, Author_FamilyName_2, VolumeID, FirstPage, Author_FamilyName_1, Year</td><td>CrossRef</td></tr><tr><td>CR59</td><td>BibArticle</td><td>Chavez-Noriega LE, Crona JH, Washburn MS, Urrutia A, Elliott KJ, Johnson EC. Pharmacological characterization of recombinant human neuronal nicotinic acetylcholine receptors h&#945;2&#946;2, h&#945;2&#946;4, h&#945;3&#946;2, h&#945;3&#946;4, h&#945;4&#946;2, h&#945;4&#946;4 and h&#945;7 expressed in Xenopus oocytes.<Emphasis Type="Italic">J Pharmacol Exp Ther.</Emphasis> 1997;280:346&#8211;356.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR60</td><td>BibArticle</td><td>Kuryatov A, Olale F, Cooper J, Choi J, Lindstrom J. Human &#945;6 subtypes: subunit composition, assembly and pharmacological responses.<Emphasis Type="Italic">Neuropharmacology</Emphasis>. 2000;39:2570&#8211;2590.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR61</td><td>BibArticle</td><td>Papke RL. The kinetic properties of neuronal nicotinic receptors: genetic basis of functional diversity.<Emphasis Type="Italic">Prog Neurobiol</Emphasis>. 1993;41:509&#8211;531.</td><td><a href=http://dx.doi.org/10.1016/0301-0082(93)90028-Q>10.1016/0301-0082(93)90028-Q</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>FirstPage, ArticleTitle, VolumeID, Year, Author_FamilyName_1</td><td>CrossRef</td></tr><tr><td>CR62</td><td>BibArticle</td><td>Sgard F, Charpantier E, Bertrand S, et al. A novel human nicotinic receptor subunit, &#945;10 that confers functionality to the &#945;9-subunit.<Emphasis Type="Italic">Mol Pharmacol</Emphasis>. 2002;61:150&#8211;159.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR63</td><td>BibArticle</td><td>Whiting P, Schoepfer R, Lindstrom J, Priestley T. Structural and pharmacological characterization of the major brain nicotinic acetylcholine receptor subtype stably expressed in mouse fibroblasts.<Emphasis Type="Italic">Mol Pharmacol</Emphasis>. 1991;40:463&#8211;472.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR64</td><td>BibArticle</td><td>Flores CM, Rogers SW, Pabreza LA, Wolfe BB, Kellar KJ. A subtype of nicotinic cholinergic receptor in rat brain is composed of &#945;4 and &#946;2 subunits and is up-regulated by chronic nicotine treatment.<Emphasis Type="Italic">Mol Pharmacol</Emphasis>. 1992;41:31&#8211;37.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR65</td><td>BibArticle</td><td>Peng X, Gerzanich V, Anand R, Whiting PJ, Lindstrom J. Nicotine-induced increase in the neuronal nicotinic receptors results from a decrease in the rate of receptor turnover.<Emphasis Type="Italic">Mol Pharmacol</Emphasis>. 1994;46:523&#8211;530.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR66</td><td>BibArticle</td><td>Davies AR, Hardick DJ, Blagbrough IS, Potter BV, Wolstenholme AJ, Wonnacott S. Characterization of the binding of [<Superscript>3</Superscript>H]methyllycaconitine: a new radioligand for labeling &#945;7-type neuronal nicotinic acetylcholine receptors.<Emphasis Type="Italic">Neuropharmacology</Emphasis>. 1999;38:679&#8211;690.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR67</td><td>BibArticle</td><td>Wada E, Wada K, Boulter J, et al. Distribution of alpha 2, alpha 3, alpha 4 and beta 2 neuronal nicotinic receptor subunit mRNAs in the central nervous system: A hybridization histochemical study in the rat.<Emphasis Type="Italic">J Comp Neurol</Emphasis>. 1989;284:314&#8211;335.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR68</td><td>BibArticle</td><td>Deneris ES, Boulter J, Swanson LW, Patrick J, Heinemann S. &#946;3: a new member of nicotinic acetylcholine receptor gene family is expressed in brain.<Emphasis Type="Italic">J Biol Chem</Emphasis>. 1989;264:6268&#8211;6272.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR69</td><td>BibArticle</td><td>Klink R, d'Exaerde AA, Zoli M, Changeux JP. Molecular and physiological diversity of nicotinic acetylcholine receptors in the midbrain dopaminergic nuclei.<Emphasis Type="Italic">J Neurosci</Emphasis>. 2001;21:1452&#8211;1463.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR70</td><td>BibArticle</td><td>Azam L, Winzer-Serjhan UH, Chen Y, Leslie FM. Expression of neuronal nicotinic acetylcholine receptor subunit mRNAs within midbrain dopamine neurons.<Emphasis Type="Italic">J Comp Neurol</Emphasis>. 2002;444:260&#8211;274.</td><td><a href=http://dx.doi.org/10.1002/cne.10138>10.1002/cne.10138</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>VolumeID, ArticleTitle, FirstPage, Author_FamilyName_1, Year</td><td>CrossRef</td></tr><tr><td>CR71</td><td>BibArticle</td><td>Lukas RJ, Changeux JP, Le Novere N, et al. International Union of Pharmacology. XX. Current status of the nomenclature for nicotinic acetylcholine receptors and their subunits.<Emphasis Type="Italic">Pharmacol Rev</Emphasis>. 1999;51:397&#8211;401.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR72</td><td>BibArticle</td><td>Kulak JM, Nguyen TA, Olivera BM, McIntosh JM. Alpha-conotoxin MII blocks nicotine-stimulated dopamine release in rat striatal synaptosomes.<Emphasis Type="Italic">J Neurosci</Emphasis>. 1997;17:5263&#8211;5270.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR73</td><td>BibArticle</td><td>Kaiser SA, Soliakov L, Harvey SC, Luetje CW, Wonnacott S. Differential inhibition by &#945;-conotoxin-MII of the nicotinic stimulation of [<Superscript>3</Superscript>H]dopamine release from rat striatal synaptosomes and slices.<Emphasis Type="Italic">J Neurochem</Emphasis>. 1998;70:1069&#8211;1076.</td><td>&nbsp;</td><td><a href=http://dx.doi.org/10.1046/j.1471-4159.1998.70031069.x>10.1046/j.1471-4159.1998.70031069.x</a></td><td><b>CrossRef-Meta</b></td>
<td>FirstPage, Author_FamilyName_2, VolumeID, Author_FamilyName_1</td><td>CrossRef</td></tr><tr><td>CR74</td><td>BibArticle</td><td>Grady SR, Meinerz NM, Cao J, et al. Nicotine agonists stimulate acetylcholine release from mouse interpeduncular nucleus: a function mediated by a different nAChR than dopamine release from striatum.<Emphasis Type="Italic">J Neurochem</Emphasis>. 2001;76:258&#8211;268.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR75</td><td>BibArticle</td><td>Grinevich VP, Crooks PA, Sumithran SP, Haubner AJ, Ayers JT, Dwoskin LP.<Emphasis Type="Italic">N-n</Emphasis>-Alkylpyridinium analogs, a novel class of nicotinic receptor antagonists: selective inhibition of nicotine-evoked [<Superscript>3</Superscript>H]dopamine overflow from superfused rat striatal slices.<Emphasis Type="Italic">J Pharmacol Exp Ther</Emphasis>. 2003;306:1011&#8211;1020.</td><td>&nbsp;</td><td><a href=http://dx.doi.org/10.1124/jpet.103.051789>10.1124/jpet.103.051789</a></td><td><b>CrossRef-Meta</b></td>
<td>FirstPage, VolumeID, Year, Author_FamilyName_1</td><td>CrossRef</td></tr><tr><td>CR76</td><td>BibArticle</td><td>Dwoskin LP, Sumithran SP, Zhu J, Deaciuc AG, Ayers JT, Crooks PA. Subtype-selective nicotinic receptor antagonists: potential as tobacco use cessation agents.<Emphasis Type="Italic">Bioorg Med Chem Lett</Emphasis>. 2004;14:1863&#8211;1867.</td><td><a href=http://dx.doi.org/10.1016/j.bmcl.2003.10.073>10.1016/j.bmcl.2003.10.073</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>VolumeID, Author_FamilyName_2, FirstPage, ArticleTitle, Author_FamilyName_1, Year</td><td>CrossRef</td></tr><tr><td>CR77</td><td>BibArticle</td><td>Luetje CW, Wada K, Rogers S, et al. Neurotoxins distinguish between different neuronal nicotinic acetylcholine receptor subunit combinations.<Emphasis Type="Italic">J Neurochem</Emphasis>. 1990;55:632&#8211;640.</td><td><a href=http://dx.doi.org/10.1111/j.1471-4159.1990.tb04180.x>10.1111/j.1471-4159.1990.tb04180.x</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>ArticleTitle, FirstPage, Author_FamilyName_2, VolumeID, Year, Author_FamilyName_1</td><td>CrossRef</td></tr><tr><td>CR78</td><td>BibArticle</td><td>Cartier GE, Yoshikami D, Gray WR, Luo S, Olivera BM, McIntosh JM. A new &#945;-conotoxin which targets &#945;3&#946;2 nicotinic acetylcholine receptors.<Emphasis Type="Italic">J Biol Chem</Emphasis>. 1996;271:7522&#8211;7528.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR79</td><td>BibArticle</td><td>Harvey SC, McIntosh JM, Cartier GE, Maddox FN, Luetje CW. Determinants of specificity for &#945;-conotoxin MII on &#945;3&#946;2 neuronal nicotinic receptors.<Emphasis Type="Italic">Mol Pharmacol</Emphasis>. 1997;51:336&#8211;342.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR80</td><td>BibArticle</td><td>Schulz DW, Zigmond RE. Neuronal bungarotoxin blocks the nicotinic stimulation of endogenous dopamine release from rat striatum.<Emphasis Type="Italic">Neurosci Lett</Emphasis>. 1989;98:310&#8211;316.</td><td><a href=http://dx.doi.org/10.1016/0304-3940(89)90420-5>10.1016/0304-3940(89)90420-5</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>FirstPage, ArticleTitle, VolumeID, Author_FamilyName_2, Year, Author_FamilyName_1</td><td>CrossRef</td></tr><tr><td>CR81</td><td>BibArticle</td><td>Picciotto MR, Zoli M, Rimondini R, et al. Acetylcholine receptors containing the &#946;2 subunit are invilved in the reinforcing properties of nicotine.<Emphasis Type="Italic">Nature</Emphasis>. 1998;391:173&#8211;177.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR82</td><td>BibArticle</td><td>Whiteaker P, Marks MJ, Grady SR, et al. Pharmacological and null mutation approaches reveal nicotinic receptor diversity.<Emphasis Type="Italic">Eur J Pharmacol</Emphasis>. 2000;393:123&#8211;135.</td><td><a href=http://dx.doi.org/10.1016/S0014-2999(00)00052-2>10.1016/S0014-2999(00)00052-2</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>ArticleTitle, FirstPage, Author_FamilyName_2, VolumeID, Year, Author_FamilyName_1</td><td>CrossRef</td></tr><tr><td>CR83</td><td>BibArticle</td><td>Grady SR, Murphy KL, Cao J, Marks MJ, McIntosh JM, Collins AC. Characterization of nicotinic agonist-induced [<Superscript>3</Superscript>H]dopamine release from synaptosomes prepared from four mouse brain regions.<Emphasis Type="Italic">J Pharmacol Exp Ther</Emphasis>. 2002;301:651&#8211;660.</td><td>&nbsp;</td><td><a href=http://dx.doi.org/10.1124/jpet.301.2.651>10.1124/jpet.301.2.651</a></td><td><b>CrossRef-Meta</b></td>
<td>Year, Author_FamilyName_1, FirstPage, VolumeID</td><td>CrossRef</td></tr><tr><td>CR84</td><td>BibArticle</td><td>Champtiaux N, Han ZY, Bessis A, et al. Distribution and pharmacology of alpha 6-containing nicotinic acetylcholine receptors analyzed with mutant mice.<Emphasis Type="Italic">J Neurosci</Emphasis>. 2002;22:1208&#8211;1217.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR85</td><td>BibArticle</td><td>Champtiaux N, Gotti C, Cordero-Erausquin M, et al. Subunit composition of functional nicotinic receptors in dopaminergic neurons investigated with knock-out mice.<Emphasis Type="Italic">J Neurosci</Emphasis>. 2003;23:7820&#8211;7829.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR86</td><td>BibArticle</td><td>Whiteaker P, Peterson CG, Xu W, et al. The role of the &#945;3 subunit in neuronal nicotinic biding populations.<Emphasis Type="Italic">J Neurosci</Emphasis>. 2002;22:2522&#8211;2529.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR87</td><td>BibArticle</td><td>McIntosh JM, Azam L, Staheli S, et al. Analogs of &#945;-conotoxin MII are selective for &#945;6-containing nicotinic acetylcholine receptors.<Emphasis Type="Italic">Mol Pharmacol</Emphasis>. 2004;65:944&#8211;952.</td><td>&nbsp;</td><td><a href=http://dx.doi.org/10.1124/mol.65.4.944>10.1124/mol.65.4.944</a></td><td><b>CrossRef-Meta</b></td>
<td>Author_FamilyName_1, Year, VolumeID, FirstPage</td><td>CrossRef</td></tr><tr><td>CR88</td><td>BibArticle</td><td>Le Novere N, Zoli M, Changeux JP. Neuronal nicotine receptor &#945;6 subunit mRNA is selectively concentrated in catecholaminergic nuclei of the rat brain.<Emphasis Type="Italic">Eur J Neurosci</Emphasis>. 1996;8:2428&#8211;2439.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR89</td><td>BibArticle</td><td>Zoli M, Moretti M, Zanardi A, McIntosh JM, Clementi F, Gotti C. Identification of the nicotinic receptor subtypes expressed on dopaminergic terminals in the rat striatum.<Emphasis Type="Italic">J Neurosci</Emphasis>. 2002;22:8785&#8211;8789.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR90</td><td>BibArticle</td><td>Cui C, Booker TK, Allen RS, et al. The &#946;3 nicotinic receptor subunit: a component of &#945;-conotoxin MII-binding nicotinic acetylcholine receptors that modulate dopamine release and related behaviors.<Emphasis Type="Italic">J Neurosci</Emphasis>. 2003;23:11045&#8211;11053.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR91</td><td>BibArticle</td><td>Goldner FM, Dineley KT, Patrick JW. Immunohistochemical localization of the nicotinic acetylcholine receptor subunit &#945;6 to dopaminergic neurons in the substantia nigra and ventral tegmental area.<Emphasis Type="Italic">Neuroreport</Emphasis>. 1997;8:2739&#8211;2742.</td><td><a href=http://dx.doi.org/10.1097/00001756-199708180-00019>10.1097/00001756-199708180-00019</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR92</td><td>BibArticle</td><td>Charpantier E, Barneoud P, Moser P, Besnard F, Sgard F. Nicotinic acetylcholine subunit mRNA expression in dopaminergic neurons of the rat substantia nigra and ventral tegmental area.<Emphasis Type="Italic">Neuroreport</Emphasis>. 1998;9:3097&#8211;3101.</td><td><a href=http://dx.doi.org/10.1097/00001756-199809140-00033>10.1097/00001756-199809140-00033</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>ArticleTitle, FirstPage, JournalTitle, VolumeID, Year, Author_FamilyName_1</td><td>CrossRef</td></tr><tr><td>CR93</td><td>BibArticle</td><td>Salminen O, Murphy KL, McIntosh JM, et al. Subunit composition and pharmacology of two classes of striatal presynaptic nicotinic acetylcholine receptors mediating dopamine release in mice.<Emphasis Type="Italic">Mol Pharmacol</Emphasis>. 2004;65:1526&#8211;1535.</td><td><a href=http://dx.doi.org/10.1124/mol.65.6.1526>10.1124/mol.65.6.1526</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>Author_FamilyName_1, Year, VolumeID, ArticleTitle, FirstPage</td><td>CrossRef</td></tr><tr><td>CR94</td><td>BibArticle</td><td>Zwart R, Vijverberg HP. Four pharmacologically distinct subtypes of alpha4beta2 nicotinic acetylcholine receptor expressed in<Emphasis Type="Italic">Xenopus laevis</Emphasis> oocytes.<Emphasis Type="Italic">Mol Pharmacol</Emphasis>. 1998;54:1124&#8211;1131.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR95</td><td>BibArticle</td><td>Lopez-Hernandez GY, Sanchez-Padilla J, Ortiz-Acevedo A, et al. Nicotine-induced upregulation and desensitization of &#945; 4&#946;2 neuronal nicotinic receptors depend on subunit ratio.<Emphasis Type="Italic">J Biol Chem</Emphasis>. 2004;279:38007&#8211;38015.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR96</td><td>BibArticle</td><td>Nelson ME, Kuryatov A, Choi CH, Zhou Y, Lindstrom J. Alternate stoichiometries of alpha4beta2 nicotinic acetylcholine receptors.<Emphasis Type="Italic">Mol Pharmacol</Emphasis>. 2003;63:332&#8211;341.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR97</td><td>BibArticle</td><td>Crooks PA, Ravard A, Wilkins LH, Teng LH, Buxton ST, Dwoskin LP. Inhibition of nicotine-evoked [<Superscript>3</Superscript>H]dopamine release by pyridino<Emphasis Type="Italic">N</Emphasis>-substituted nicotine analogues: a new class of nicotinic antagonist.<Emphasis Type="Italic">Drug Dev Res</Emphasis>. 1995;36:91&#8211;102.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR98</td><td>BibArticle</td><td>Dwoskin LP, Xu R, Ayers JT, Crooks PA. Recent developments in neuronal nicotinic acetylcholine receptor antagonists.<Emphasis Type="Italic">Exp Opin Ther Pat</Emphasis>. 2000;10:1561&#8211;1581.</td><td><a href=http://dx.doi.org/10.1517/13543776.10.10.1561>10.1517/13543776.10.10.1561</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>Author_FamilyName_1, Year, Author_FamilyName_2, VolumeID, ArticleTitle, FirstPage</td><td>CrossRef</td></tr><tr><td>CR99</td><td>BibArticle</td><td>Dwoskin LP, Crooks PA. Competitive neuronal nicotinic receptor antagonists: a new direction for drug discovery.<Emphasis Type="Italic">J Pharmacol Exp Ther</Emphasis>. 2001;298:395&#8211;402.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR100</td><td>BibArticle</td><td>Wilkins LH, Grinevich VP, Ayers JT, Crooks PA, Dwoskin LP.<Emphasis Type="Italic">N-n</Emphasis>-Alkylnicotinium analogs, a novel class of nicotinic receptor antagonists: interaction with &#945;4&#946;2<Superscript>*</Superscript> and &#945;7<Superscript>*</Superscript> neuronal nicotinic receptors.<Emphasis Type="Italic">J Pharmacol Exp Ther</Emphasis>. 2003;304:400&#8211;410.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR101</td><td>BibUnstructured</td><td><aug><span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Crooks</span> <span style='background:#DDDDDD'>PA</span></span>, <span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Xu</span> <span style='background:#DDDDDD'>R</span></span>, <span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Sumithran</span> <span style='background:#DDDDDD'>SP</span></span>, <span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Deaciue</span> <span style='background:#DDDDDD'>AG</span></span>, <span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Dwoskin</span> <span style='background:#DDDDDD'>LP</span></span></aug>. <span style='background:#CCCCFF'>NONI and NDNI analogs: structural modification of <i>theN-n</i>-alkyl moiety and the effect on neuronal nicotinic receptor activity</span>. <span style='background:#CCFF99'><i>Bioorg Med Chem</i></span> <span style='background:#66FF66'>2005</span>.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR102</td><td>BibArticle</td><td>Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.<Emphasis Type="Italic">Anal Biochem</Emphasis>. 1976;72:248&#8211;254.</td><td><a href=http://dx.doi.org/10.1016/0003-2697(76)90527-3>10.1016/0003-2697(76)90527-3</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>Year, Author_FamilyName_1, ArticleTitle, FirstPage, VolumeID</td><td>CrossRef</td></tr><tr><td>CR103</td><td>BibArticle</td><td>Miller DK, Crooks PA, Dwoskin LP. Lobeline inhibits nicotine-evoked [<Superscript>3</Superscript>H]dopamine overflow from rat striatal slices and nicotine-evoked<Superscript>86</Superscript>Rb<Superscript>+</Superscript> efflux from thalamic synaptosomes.<Emphasis Type="Italic">Neuropharmacology</Emphasis>. 2000;39:2654&#8211;2662.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR104</td><td>BibArticle</td><td>Zhu J, Crooks PA, Ayers JT, Sumithran SP, Dwoskin LP.<Emphasis Type="Italic">N-n</Emphasis>-Alkylnicotinium and<Emphasis Type="Italic">N-n</Emphasis>-alkylpyridinium analogs inhibit the dopamine transporter: Selectivity as nicotinic receptor antagonists.<Emphasis Type="Italic">Drug Dev Res</Emphasis>. 2003;60:270&#8211;284.</td><td>&nbsp;</td><td><a href=http://dx.doi.org/10.1002/ddr.10328>10.1002/ddr.10328</a></td><td><b>CrossRef-Meta</b></td>
<td>FirstPage, VolumeID, Author_FamilyName_2, Year, Author_FamilyName_1</td><td>CrossRef</td></tr><tr><td>CR105</td><td>BibArticle</td><td>Cheng Y, Prusoff WH. Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50 percent inhibition (I<Subscript>50</Subscript>) of an enzymatic reaction.<Emphasis Type="Italic">Biochem Pharmacol</Emphasis>. 1973;22:3099&#8211;3108.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR106</td><td>BibArticle</td><td>McGehee DS, Heath MJ, Gelber S, Devay P, Role LW. Nicotinic enhancement of fast excitatory synaptic transmission in CNS by presynaptic receptors.<Emphasis Type="Italic">Science</Emphasis>. 1995;269:1692&#8211;1696.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR107</td><td>BibArticle</td><td>Kaiser SA, Wonnacott S. &#945;-Bungarotoxin-sensitive nicotinic receptors indirectly modulate [<Superscript>3</Superscript>H]dopamine release in rat striatal slices via glutamate release.<Emphasis Type="Italic">Mol Pharmacol</Emphasis>. 2000;58:312&#8211;318.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr></table>